Benazepril: Nephropathy (Non-diabetic)

Area of Science:

• Pharmacy
• Pharmacology
• Drug Utilization

Background:

• Off-label drug use refers to prescribing medications for conditions not approved by the US Food and Drug Administration (FDA).
• Practitioners require reliable resources to navigate the complexities of unapproved drug indications.
• Existing literature on off-label drug use can be fragmented and challenging to access.

Purpose of the Study:

• To introduce a practitioner-oriented resource, Off-Label Drug Facts, for information on specific unapproved drug uses.
• To enable healthcare professionals to efficiently identify and assess published studies on off-label drug applications.
• To support evidence-based decision-making in patient care scenarios involving off-label drug use.

Main Methods:

• Extraction of information from the Off-Label Drug Facts publication.
• Literature review and synthesis focused on unapproved drug indications.
• Provision of references for further in-depth information.

Main Results:

• A curated guide to off-label drug uses is now available.
• The resource facilitates rapid identification of relevant published studies.
• The guide aids in determining the rationality of specific off-label drug uses in clinical practice.

Conclusions:

• Off-Label Drug Facts serves as a valuable tool for clinicians.
• The publication supports informed patient care by consolidating information on unapproved drug uses.
• Healthcare professionals can utilize this resource to enhance their understanding and application of off-label drug information.